Pharmaceutical packaging is more than a visual representation of medicine. The packaging and its artwork must communicate critical product information accurately. It should support safe use and meet the regulatory requirements that apply. Accommodating manufacturing and packaging constraints and maintaining consistency across markets and product presentations are also quite challenging.
This makes pharmaceutical packaging graphic design a multidisciplinary approach. Let’s look into the challenges it brings and how to remedy them.
Problems & Solutions of Pharmaceutical Packaging Graphic Design
The key challenges that pharmaceutical packaging graphic design brings are given below. The solutions have also been given here:
1. Balancing Regulatory Information with Effective Design
Fitting extensive regulatory and product information into a compact packaging artwork is difficult. The readability may get compromised within the limited physical space. The manufacturer cannot compromise on mandatory information. They must keep it and let the branding visual elements take a backseat.
The FDA’s guidance on container labels and carton labelling specifically focuses on designing critical information in a way that supports safe dispensing, administration and use and helps minimise medication errors.
Remedy
A pharmaceutical artwork process should establish the regulatory and mandatory information hierarchy before finalising the visual design. Priority should be given to critical information according to its importance to identification and safe use. There should be sufficient space reserved for mandatory statements, variable data, and machine-readable elements.
2. Maintaining Readability & Clear Information Hierarchy
Pharmaceutical packaging can contain a large amount of information on relatively small surfaces. That’s why simply including all the required text is not enough. The information needs to remain easy to find and read.
Poor typography, crowded layouts, insufficient contrast, inconsistent text hierarchy, or excessive decorative elements can make important information difficult to differentiate.
The EMA’s packaging guidance highlights readability as an important part of the presentation of medicine information. Its mock-up process considers the readability of outer and immediate packaging and package leaflets.
Remedy
Pharmaceutical artwork should use the following:
- Clear typographic hierarchy
- Appropriate font sizes
- Adequate spacing
- Strong contrast between text and background
- Consistent alignment
- Logical grouping of related information
- Clear differentiation between product name, strength and dosage form
- Sufficient separation between different strengths or presentations
The objective should be to make important information easy to locate rather than simply making the packaging visually attractive.
3. Preventing Medication Errors through Packaging Design
Packaging design can contribute to medication-use errors when similar products, strengths, or presentations are difficult to differentiate. Different strengths of the same medicine, various dosage forms & pack sizes, products with similar names, products with the same therapeutic range, and similar-appearing cartons or containers are some of the factors that make it important for pharmaceutical companies.
The FDA specifically recommends considering safety aspects of container labels and carton labelling design to reduce the potential for medication errors.
Remedy
Artwork teams should consider differentiation at the design stage instead of relying solely on the product name. This can be in clear strength of presentation or consistent but distinguishable product architecture. Proper colour use, spacing, and distinct information hierarchy are also helpful. Placing key information consistently and avoiding unnecessary visual similarities between products that could be confused are great ways of reducing medication errors.
The goal is to make every SKU look different and create a systematic packaging architecture. It should allow related products to remain recognisable while reducing opportunities for confusion.
4. Managing Multiple Markets & Regulatory Requirements
Internationally operating pharmaceutical companies need to manage multiple regulatory markets for their packaging artwork. The EU has requirements for safety features on the packaging of most prescription medicines and certain non-prescription medicines. It includes a unique identifier carried by a 2D barcode and an anti-tampering device.
In the United States, the Drug Supply Chain Security Act (DSCSA) has requirements for product identification and package-level tracing for some prescription drugs. India also has its own regulatory requirements for drug labelling and packaging.
Remedy
Artwork should be managed on a market-by-market basis, with a controlled master artwork and clearly documented market-specific variations. Don’t assume that one global artwork can simply be translated or resized. Teams should identify the regulatory requirements for each intended market before artwork development.
5. Accommodating Serialisation, Barcodes, and Variable Data
Machine-readable information and variable data need to be incorporated into modern pharmaceutical packaging. Barcodes, QR codes, product identifiers, expiry dates, and such elements create a specific artwork challenge. These need to be scannable, correctly positioned, and visually distinguishable while fitting into an already crowded design.
FDA’s DSCSA guidance requires product identifiers on applicable drug packages and explains the use of 2D data matrix barcodes for package-level product identification. In the EU, the unique identifier is carried by a 2D barcode as part of the applicable safety-feature requirements.
Remedy
Artwork teams should reserve dedicated areas for machine-readable elements early in the design process and verify the following:
- Required code type
- Required data fields
- Human-readable information
- Placement
- Quiet zones and surrounding space where applicable
- Print quality
- Scannability
- Variable-data positioning
- Market-specific requirements
Serialisation should therefore be treated as part of the artwork and packaging workflow rather than something added at the final printing stage.
6. Managing Different Product Names Across Markets
A pharmaceutical product may not always be marketed under exactly the same name in every country. When a company has to maintain different versions of the brand name, generic or non-proprietary name, strength, dosage form, regulatory text, manufacturer information, and local marketing-authorisation information, the challenge becomes multifold.
The overall packaging architecture may also need to remain recognisable as part of the same corporate or product family.
Remedy
A structured artwork system should separate global design elements from market-specific regulatory content. That’s how companies managing large portfolios across several markets can maintain brand consistency, create country-specific artwork, minimise transcription errors, etc., with ease.
7. Fitting Pharmaceutical Artwork into Physical Packaging Constraints
Not every packaging component provides the same amount of usable space. The available surface area, folds, seams, curves, print restrictions and packaging-material characteristics can all affect how information can be presented. A design that looks correct on a flat digital screen may not work effectively once converted into the final three-dimensional pack.
The EMA’s definition of a packaging mock-up reflects this principle. A mock-up replicates the flat artwork design after cutting and folding to assess the three-dimensional presentation of the packaging text.
Remedy
Artwork development should account for the physical packaging structure from the beginning. This includes reviewing the following:
- Die lines
- Bleed and safe areas
- Folding panels
- Seams
- Curved surfaces
- Print limitations
- Barcode placement
- Variable-data areas
- Minimum readable text
- Primary versus secondary packaging
Artwork should be checked in both flat and assembled form before final approval.
8. Preserving Product Quality through Appropriate Packaging
Packaging systems are designed to help protect the product from factors that could affect its quality, stability, or integrity during storage, handling, and distribution.
ICH’s quality risk-management framework emphasises that quality-risk decisions should ultimately be linked to patient protection. The factors to be considered here include temperature, light, moisture, oxygen, contamination, physical damage, and compatibility between product and packaging components.
Remedy
Packaging artwork teams should work alongside packaging development, quality, and regulatory teams so that the artwork reflects the approved packaging configuration and product requirements. Graphic design should not be separated from the technical packaging system.
Conclusion
Pharmaceutical packaging graphic design involves considerably more than creating an attractive carton or label. A structured artwork process can help pharmaceutical companies manage every challenge. With the right approach, pharmaceutical packaging can remain visually consistent and brand-aligned while also supporting regulatory compliance, product integrity, traceability, and safe medicine use.
For support with pharmaceutical packaging artwork, market-specific labelling, artwork review, and packaging compliance, explore Artixio’s regulatory artwork and labeling services.
FAQs
1. What are the key challenges in pharmaceutical packaging artwork design?
Key challenges include presenting extensive regulatory information in limited space, maintaining readability, differentiating products and strengths, accommodating barcodes and serialisation elements, managing multilingual and market-specific requirements, and maintaining consistency across packaging components.
2. How can pharmaceutical companies reduce errors in packaging artwork?
Companies can reduce artwork errors through controlled source content, regulatory review, proofreading, cross-component checks, version control, technical artwork verification, and a defined approval and release process. Artwork should also be reviewed for readability and potential medication-use confusion.
3. Does pharmaceutical packaging artwork need to be adapted to different countries?
Yes. Pharmaceutical packaging may need market-specific adaptations because regulatory requirements, languages, product information, safety features, traceability elements, pack sizes and labelling requirements can differ between jurisdictions. A controlled global artwork system with documented local variations can help maintain consistency while meeting individual market requirements.
